Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA, Europe, Canada, and Australia
{{output}}
Background: Monitoring of adverse events for aesthetic BoNT-A (BoNT-A) through pharmacovigilance databases provides critical insight into real-world safety profiles. Previous analyses suggested substantial underreporting, yet com... ...
